Literature DB >> 16817193

Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation.

Kana Tojo1, Yoshiki Sekijima, Tamio Suzuki, Noriyuki Suzuki, Yasushi Tomita, Kunihiro Yoshida, Takao Hashimoto, Shu-Ichi Ikeda.   

Abstract

A family with dystonia associated with dyschromatosis symmetrica hereditaria (DSH), mental deterioration, and tissue calcification is described. The proband possessed an adenosine deaminase acting on the RNA 1 gene (ADAR1) mutation Gly1007Arg. This ADAR1 mutation could disturb RNA editing at Q/R sites of glutamate receptor in the brain and increase Ca(2+) influx into neurons, which is thought to induce dystonia and mental deterioration. The observations in our family raise the possibility that the ADAR1 mutation might be a direct cause or a predisposing factor for heredodegenerative dystonia. Further investigation of ADAR1 mutations will shed light on the genotype-phenotype correlation in DSH. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16817193     DOI: 10.1002/mds.21011

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  Transcriptome-wide identification of adenosine-to-inosine editing using the ICE-seq method.

Authors:  Tsutomu Suzuki; Hiroki Ueda; Shunpei Okada; Masayuki Sakurai
Journal:  Nat Protoc       Date:  2015-04-09       Impact factor: 13.491

Review 2.  Molecular diversity through RNA editing: a balancing act.

Authors:  Sanaz Farajollahi; Stefan Maas
Journal:  Trends Genet       Date:  2010-04-13       Impact factor: 11.639

3.  A Phenotypic Screen for Functional Mutants of Human Adenosine Deaminase Acting on RNA 1.

Authors:  Yuru Wang; Jocelyn Havel; Peter A Beal
Journal:  ACS Chem Biol       Date:  2015-09-22       Impact factor: 5.100

4.  Case Report: Aicardi-Goutières Syndrome Type 6 and Dyschromatosis Symmetrica Hereditaria With Congenital Heart Disease and Mitral Valve Calcification - Phenotypic Variants Caused by Adenosine Deaminase Acting on the RNA 1 Gene Homozygous Mutations.

Authors:  Lingjuan Liu; Lu Zhang; Peng Huang; Jie Xiong; Yangyang Xiao; Cheng Wang; Dingan Mao; Liqun Liu
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

5.  Genetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological Disease.

Authors:  Gillian I Rice; Naoki Kitabayashi; Magalie Barth; Tracy A Briggs; Annabel C E Burton; Maria Luisa Carpanelli; Alfredo M Cerisola; Cindy Colson; Russell C Dale; Federica Rachele Danti; Niklas Darin; Begoña De Azua; Valentina De Giorgis; Christian G L De Goede; Isabelle Desguerre; Corinne De Laet; Atieh Eslahi; Michael C Fahey; Penny Fallon; Alex Fay; Elisa Fazzi; Mark P Gorman; Nirmala Rani Gowrinathan; Marie Hully; Manju A Kurian; Nicolas Leboucq; Jean-Pierre S-M Lin; Matthew A Lines; Soe S Mar; Reza Maroofian; Laura Martí-Sanchez; Gary McCullagh; Majid Mojarrad; Vinodh Narayanan; Simona Orcesi; Juan Dario Ortigoza-Escobar; Belén Pérez-Dueñas; Florence Petit; Keri M Ramsey; Magnhild Rasmussen; François Rivier; Pilar Rodríguez-Pombo; Agathe Roubertie; Tommy I Stödberg; Mehran Beiraghi Toosi; Annick Toutain; Florence Uettwiller; Nicole Ulrick; Adeline Vanderver; Amy Waldman; John H Livingston; Yanick J Crow
Journal:  Neuropediatrics       Date:  2017-04-10       Impact factor: 1.947

6.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.

Authors:  Gillian I Rice; Paul R Kasher; Gabriella M A Forte; Niamh M Mannion; Sam M Greenwood; Marcin Szynkiewicz; Jonathan E Dickerson; Sanjeev S Bhaskar; Massimiliano Zampini; Tracy A Briggs; Emma M Jenkinson; Carlos A Bacino; Roberta Battini; Enrico Bertini; Paul A Brogan; Louise A Brueton; Marialuisa Carpanelli; Corinne De Laet; Pascale de Lonlay; Mireia del Toro; Isabelle Desguerre; Elisa Fazzi; Angels Garcia-Cazorla; Arvid Heiberg; Masakazu Kawaguchi; Ram Kumar; Jean-Pierre S-M Lin; Charles M Lourenco; Alison M Male; Wilson Marques; Cyril Mignot; Ivana Olivieri; Simona Orcesi; Prab Prabhakar; Magnhild Rasmussen; Robert A Robinson; Flore Rozenberg; Johanna L Schmidt; Katharina Steindl; Tiong Y Tan; William G van der Merwe; Adeline Vanderver; Grace Vassallo; Emma L Wakeling; Evangeline Wassmer; Elizabeth Whittaker; John H Livingston; Pierre Lebon; Tamio Suzuki; Paul J McLaughlin; Liam P Keegan; Mary A O'Connell; Simon C Lovell; Yanick J Crow
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

7.  Mechanistic insights into editing-site specificity of ADARs.

Authors:  Ashani Kuttan; Brenda L Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

8.  Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures.

Authors:  Tiong Yang Tan; Jiří Sedmík; Mark P Fitzgerald; Rivka Sukenik Halevy; Liam P Keegan; Ingo Helbig; Lina Basel-Salmon; Lior Cohen; Rachel Straussberg; Wendy K Chung; Mayada Helal; Reza Maroofian; Henry Houlden; Jane Juusola; Simon Sadedin; Lynn Pais; Katherine B Howell; Susan M White; John Christodoulou; Mary A O'Connell
Journal:  Am J Hum Genet       Date:  2020-03-26       Impact factor: 11.025

9.  A biochemical landscape of A-to-I RNA editing in the human brain transcriptome.

Authors:  Masayuki Sakurai; Hiroki Ueda; Takanori Yano; Shunpei Okada; Hideki Terajima; Toutai Mitsuyama; Atsushi Toyoda; Asao Fujiyama; Hitomi Kawabata; Tsutomu Suzuki
Journal:  Genome Res       Date:  2014-01-09       Impact factor: 9.043

10.  Editing independent effects of ADARs on the miRNA/siRNA pathways.

Authors:  Bret S E Heale; Liam P Keegan; Leeanne McGurk; Gracjan Michlewski; James Brindle; Chloe M Stanton; Javier F Caceres; Mary A O'Connell
Journal:  EMBO J       Date:  2009-08-27       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.